Bank Of America Corp Bio Xcel Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 73,426 shares of BTAI stock, worth $41,852. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,426

Previous 47,368 55.01%

Holding current value

$41,852

Previous $133,000 30.08%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.14 - $2.97 $29,706 - $77,392	26,058 Added 55.01%	73,426 $93,000
Q1 2024 May 15, 2024	SELL	$1.95 - $4.04 $111,073 - $230,122	-56,961 Reduced 54.6%	47,368 $133,000
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $386,658 - $918,313	-166,663 Reduced 61.5%	104,329 $307,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $446,871 - $2 Million	-69,933 Reduced 20.51%	270,992 $1.8 Million
Q1 2023 May 12, 2023	BUY	$17.7 - $33.24 $3.97 Million - $7.46 Million	224,564 Added 192.99%	340,925 $6.36 Million
Q4 2022 Feb 10, 2023	SELL	$10.25 - $22.43 $72,734 - $159,163	-7,096 Reduced 5.75%	116,361 $2.5 Million
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $171,274 - $273,824	-15,306 Reduced 11.03%	123,457 $1.46 Million
Q2 2022 Aug 12, 2022	SELL	$9.03 - $21.55 $511,097 - $1.22 Million	-56,600 Reduced 28.97%	138,763 $1.83 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $815,670 - $1.24 Million	54,378 Added 38.57%	195,363 $4.09 Million
Q4 2021 Feb 08, 2022	BUY	$20.12 - $35.09 $1.55 Million - $2.71 Million	77,276 Added 121.3%	140,985 $2.87 Million
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $361,938 - $486,279	-15,182 Reduced 19.24%	63,709 $1.93 Million
Q2 2021 Sep 13, 2021	BUY	$29.06 - $38.83 $2.29 Million - $3.06 Million	78,891 New	78,891 $2.29 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.24M

Call Options Held

101K

Put Options Held

205K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $16M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Bio Xcel Therapeutics, Inc. Transaction History